Stock comparison
FTI CONSULTING, INC is 1.9x more valuable than Astrana Health, Inc. by market capitalization ($4.73 B vs $2.56 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
FCN is larger
FTI CONSULTING, INC is 1.9x more valuable than Astrana Health, Inc. by market capitalization ($4.73 B vs $2.56 B).
Market value leader
FCN
FTI CONSULTING, INC is 1.9x more valuable than Astrana Health, Inc. by market capitalization ($4.73 B vs $2.56 B).
Revenue leader
FCN
FCN: $3.79B vs ASTH: $3.18B.
Profit leader
FCN
FCN: $270.87M vs ASTH: $24.00M.
Margin leader
FCN
FCN: 7.1% vs ASTH: 0.8% net margin.
| Metric | FCN | ASTH |
|---|---|---|
| Market cap | $4.73 B | $2.56 B |
| US-listed rank | #1467 | #1959 |
| Revenue (latest FY) | $3.79B | $3.18B |
| Net income (latest FY) | $270.87M | $24.00M |
| Net margin | 7.1% | 0.8% |
| P/E (trailing FY) | 17.5x | 106.5x |
| SEC filings | 1,986 | 1,003 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
FTI CONSULTING, INC is 1.9x more valuable than Astrana Health, Inc. by market capitalization ($4.73 B vs $2.56 B).
In their latest fiscal years, FTI CONSULTING, INC reported $3.79B in revenue while Astrana Health, Inc. reported $3.18B.
Full pages: FTI CONSULTING, INC and Astrana Health, Inc., or browse the full rankings.